Epidermolysis bullosa is characterized by fragile skin and/or mucosal surfaces along with subsequent blistering, erosions , and scarring. It can occur anywhere on the body. The blistering occurs as a result of a facile separation of the cutaneous layers, which is attributable to either genetically fault y structural protein s or acquired autoantibodie s again st those proteins.
• The congeni tal variants (epidermolysis bullosa hereditaria) are classified according to their layer of separation (epidermal or dermal) and further subdivided according to the mode of inheritance.
• The acquired type (epidermol ysis bullo sa acqui sita) is a chron ic autoimmune disorder characteri zed by the presence of autoantibodies again st type VII collagen, which make up the anchoring fibrils along the derm al-epidermal j unction.
From the House Ear Clinic, Los Angeles. Management of both form s includes avoidance of skin trauma, careful wound care, prevention of infection, and good nutrition. Several medications have been tried, but epidermolysis bullo sa remains very difficult to treat medically. Gene -repl acement therapy is bein g inve stigated as a possible treatment for some type s of the congenital variants.
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We evaluated a 63-year-old woman with a diagnosis of a congenit al variant of epidermolysis bullos a. Her manifestation included erosion and scarring along her posterior scalp (figure I ). She had experienced repeated episodes of blistering and erosion followed by scarring, which led to stenosis of her external aud itory canals (figure 2) and subsequent bilateral conductive hearing loss. She desired amplification, but her stenosis and skin erosion made her a poor candidate for hearing aid s. She eventually underwent placement of a bone-anchored hearing aid on the right side.
